News
![Renewi plc: Application for Block Listing](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Renewi plc: Application for Block Listing
![Technip Energies to Address Attendees at the Kepler Cheuvreux Autumn Conference: https://mms.businesswire.com/media/20210325005821/en/867429/5/TECHNIP_ENERGIES_LOGO_HORIZONTAL_RVB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTFHVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c93784afd984798abd396173ebfcd5dc86a60d73/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/TECHNIP_ENERGIES_LOGO_HORIZONTAL_RVB.jpg?locale=us)
Technip Energies to Address Attendees at the Kepler Cheuvreux Autumn Conference
Regulatory News:
Technip Energies (PARIS:TE) (ISIN:NL0014559478) announced today that Arnaud Pieton, Chief Executive Officer, will address attendees on Wednesday, September 14, at 12.00 CET at
![DGAP-News: Clean Logistics SE: Jürgen Akkermann appointed as CFO of Clean Logistics](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
DGAP-News: Clean Logistics SE: Jürgen Akkermann appointed as CFO of Clean Logistics
![Allane Mobility Group continues to expand its offering: Complete winter wheels now available as individual product](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Allane Mobility Group continues to expand its offering: Complete winter wheels now available as individual product
![Pharnext Announces First Patient Enrolled in Open Label Extension of the Pivotal Phase III Study of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Pharnext Announces First Patient Enrolled in Open Label Extension of the Pivotal Phase III Study of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial
![Hardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Hardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
![SWEF: Transaction in Own Shares](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
SWEF: Transaction in Own Shares
![Cairn Homes Plc: Transaction in Own Shares](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Cairn Homes Plc: Transaction in Own Shares
![Hardman & Co Research on Neodecortech (NDT.MI): Bright 1H’22, cloudy outlook](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Hardman & Co Research on Neodecortech (NDT.MI): Bright 1H’22, cloudy outlook
![Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
![FEMSA publishes the provisional interim result of the public tender offer for Valora – participation rate of 84.41%](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
FEMSA publishes the provisional interim result of the public tender offer for Valora – participation rate of 84.41%
![DGAP-Adhoc: Major shareholders intend to restructure the board of directors of the SNP SE](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
DGAP-Adhoc: Major shareholders intend to restructure the board of directors of the SNP SE
![Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTRqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8c255f1cb7b73806f677f1d1d64e93866d2979a5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Clovis_Logo_Process_Color.jpg?locale=us)
Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups
Clovis Oncology, Inc. (NASDAQ: CLVS), today announced results from a subgroup analysis of data from the monotherapy comparison of the randomized, Phase 3 ATHENA (GOG-3020/ENGOT-ov45) trial
![Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO Congress 2022: https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN29sRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2c39f3b6129a12541932c63b90c23307b141ad6b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/puma_logo_JPEG.jpg?locale=us)
Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO Congress 2022
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of updated findings from the Phase II SUMMIT basket trial of neratinib for HER2 (ERBB2)-mutant
![Viad Corp Provides Statement on Health of Pursuit President: https://mms.businesswire.com/media/20191205005099/en/583308/5/ViadBlueLogo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1daRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1d0e187cc89722b6473b930e105a5ba91d52d96f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ViadBlueLogo.jpg?locale=us)
Viad Corp Provides Statement on Health of Pursuit President
Viad Corp (NYSE: VVI), a leading global provider of extraordinary experiences, including hospitality and leisure activities, experiential marketing, and live events, today announced that David
State Street Corporation Announces Date for Release of Third-Quarter 2022 Financial Results and Conference Call Webcast
State Street Corporation (NYSE: STT) plans to announce its third-quarter 2022 financial results on Tuesday, October 18, 2022 at approximately 7:30 a.m. ET. The results will be reviewed via webcast
![MSG Sports President and CEO Andrew Lustgarten to Step Down, Effective January 1: https://mms.businesswire.com/media/20201106005470/en/836696/5/MSGS_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBODZMVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ff50b95faa28181f7f599b95cdfdbe89018c4949/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/MSGS_Logo.jpg?locale=us)
MSG Sports President and CEO Andrew Lustgarten to Step Down, Effective January 1
Madison Square Garden Sports Corp. (NYSE: MSGS) (“MSG Sports”) today announced that Andrew Lustgarten, MSG Sports’ President and Chief Executive Officer, is stepping down from his position at the
![NexPlayer To Offer Powerful Combination of Video Quality and Protection through Integration with Verimatrix Streamkeeper and Watermarking: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzFvT1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8aaf65767cc90c3a7b62ce9a2fde81548a641739/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/VMX+logo+4210606c.jpg?locale=us)
NexPlayer To Offer Powerful Combination of Video Quality and Protection through Integration with Verimatrix Streamkeeper and Watermarking
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Madrid-based NexPlayer has
![Special Committee of Startek Updates Stockholders on Status of Preliminary Non-Binding Proposal by CSP: https://mms.businesswire.com/media/20210317005065/en/865538/5/STARTEK_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDA4Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f21eaf986cc0ad1f82bf6c45c91ec1f1be7e234e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/STARTEK_logo.jpg?locale=us)
Special Committee of Startek Updates Stockholders on Status of Preliminary Non-Binding Proposal by CSP
The Special Committee of the Board of Directors of Startek, Inc. (NYSE: SRT) announced today that it has rejected the preliminary, non-binding proposal, dated August 8, 2022, by CSP Management
![DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
![Ventas to Participate in Investor Meetings at BofA Securities 2022 Global Real Estate Conference: https://mms.businesswire.com/media/20191106005316/en/282462/5/Ventas_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeW9qRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fc96c5109a64546566245501249df4a6b361210d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Ventas_logo.jpg?locale=us)
Ventas to Participate in Investor Meetings at BofA Securities 2022 Global Real Estate Conference
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at the BofA Securities 2022 Global Real Estate Conference (the “BofA
![TCS Group Holding PLC announces BOD changes](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
TCS Group Holding PLC announces BOD changes
![Fuller, Smith & Turner PLC: Holding(s) in Company](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Fuller, Smith & Turner PLC: Holding(s) in Company
![DGAP-Adhoc: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
DGAP-Adhoc: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate
![Leclanché SA: Leclanché announces changes in its Board of Directors](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)